Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Paramount Global, Raises Price Target to $28

Needham analyst Laura Martin maintains Paramount Global (NASDAQ:PARA) with a Buy and raises the price target from $23 to $28.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Needham analyst Laura Martin maintains Paramount Global (NASDAQ:PARA) with a Buy and raises the price target from $23 to $28.

SunOpta Q4 Adj. EPS $0.02 Up From $(0.01) YoY, Sales $221.29M Beat $220.60M Estimate

By Michael Horton

Today, 10:45 PM

SunOpta (NASDAQ:STKL) reported quarterly earnings of $0.02 per share. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $221.29

STKL

News
Tech

BlackBerry Granted Five U.S. Patents on Tuesday: ‘Switching between network based and relay based operation for mission critical voice call’ ‘Method and system for intelligent transportation system certificate revocation list reduction’ ‘Processing da…

By Charles Gross

Today, 10:45 PM

View patent 1 here

Arhaus Stock Gains On FY22 Guidance Boost

By Shivani Kumaresan

Today, 10:45 PM

Arhaus Inc (NASDAQ:ARHS) has raised its full-year 2022 revenue guidance from $1.173 billion – $1.193 billion to $1.223 billion – $1.228…

ARHS

Amicus Therapeutics Q4 Sales $88.10M Beat $86.29M Estimate

By Benzinga Newsdesk

Today, 10:45 PM

Amicus Therapeutics (NASDAQ:FOLD) reported quarterly sales of $88.10 million which beat the analyst consensus estimate of $86.29 million by 2.09 percent. This is a 7.23 percent increase over sales of $82.15 million the

FOLD

Needham Maintains Buy on Paramount Global, Raises Price Target to $28

Related Posts

SunOpta Q4 Adj. EPS $0.02 Up From $(0.01) YoY, Sales $221.29M Beat $220.60M Estimate

BlackBerry Granted Five U.S. Patents on Tuesday: ‘Switching between network based and relay based operation for mission critical voice call’ ‘Method and system for intelligent transportation system certificate revocation list reduction’ ‘Processing da…

Arhaus Stock Gains On FY22 Guidance Boost

Amicus Therapeutics Q4 Sales $88.10M Beat $86.29M Estimate